How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company has a market capitalization of $8.1 billion and operates through Protein Sciences, Diagnostics and Spatial Biology segments.
Companies with a market cap between $2 billion and $10 billion are typically referred to as “mid-cap stocks.” Bio-Techne sits comfortably there,